AQSZF (Aequus Pharmaceuticals) FCF Margin %: -8.24% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aequus Pharmaceuticals FCF Margin %?

Aequus Pharmaceuticals AQSZF FCF Margin % is -8.24% as of Sep. 2025. The stock has 6 warning signs investors should review. Among 963 Drug Manufacturers companies, Aequus Pharmaceuticals ranks worse than 76.43% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aequus Pharmaceuticals's Free Cash Flow for the three months ended in Sep. 2025 was $-0.02 Mil. Aequus Pharmaceuticals's Revenue for the three months ended in Sep. 2025 was $0.18 Mil. Therefore, Aequus Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2025 was -8.24%.

As of today, Aequus Pharmaceuticals's current FCF Yield % is -23.77%.

The historical rank and industry rank for Aequus Pharmaceuticals's FCF Margin % or its related term are showing as below:

AQSZF' s FCF Margin % Range Over the Past 10 Years
Min: -899.61   Med: -183.33   Max: -12.52
Current: -12.52

During the past 12 years, the highest FCF Margin % of Aequus Pharmaceuticals was -12.52%. The lowest was -899.61%. And the median was -183.33%.

AQSZF's FCF Margin % is ranked worse than
76.43% of 963 companies
in the Drug Manufacturers industry
Industry Median: 2.57 vs AQSZF: -12.52

Aequus Pharmaceuticals FCF Margin % Related Terms

Aequus Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Aequus Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aequus Pharmaceuticals FCF Margin % Chart

Aequus Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.47 -43.33 -141.54 -900.00 -283.41

Aequus Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -236.70 -35.26 13.92 -21.38 -8.24

AQSZF vs GCAN, STEK, CBSTQ: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's FCF Margin % falls into.


Aequus Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Aequus Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.162/0.41
=-283.41 %

Aequus Pharmaceuticals's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.015/0.182
=-8.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -8.24% mean?
Aequus Pharmaceuticals (AQSZF) has a FCF Margin % of -8.24% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aequus Pharmaceuticals and its competitors. According to the industry distribution chart, Aequus Pharmaceuticals ranks #736 out of 963 companies in the Drug Manufacturers industry, placing it in the top 76.4%.
Is Aequus Pharmaceuticals' FCF Margin % too high?
Aequus Pharmaceuticals' current FCF Margin % is -8.24%. Based on the distribution chart, Aequus Pharmaceuticals ranks #736 out of 963 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Aequus Pharmaceuticals' FCF Margin % compare to GCAN and STEK?
According to the Drug Manufacturers industry distribution chart, Aequus Pharmaceuticals ranks #736 out of 963 companies for FCF Margin %. This places Aequus Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aequus Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aequus Pharmaceuticals's current FCF Margin % is -8.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aequus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Aequus Pharmaceuticals (AQSZF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 74% below its estimated fair value. The current FCF Margin % is -8.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aequus Pharmaceuticals (AQSZF), the current FCF Margin % is -8.24% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aequus Pharmaceuticals Business Description

Address 200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.